Madrigal Pharmaceuticals Inc banner

Madrigal Pharmaceuticals Inc
SWB:YDO1

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
SWB:YDO1
Watchlist
Price: 460.6 EUR 7.12% Market Closed
Market Cap: €9.1B

Wall St Price Targets

YDO1 Price Targets Summary
Madrigal Pharmaceuticals Inc

Wall Street analysts forecast YDO1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for YDO1 is 570.64 EUR with a low forecast of 453.21 EUR and a high forecast of 858.6 EUR.

Lowest Forecast
Price Target
453.21 EUR
2% Downside
Average Forecast
Price Target
570.64 EUR
24% Upside
Highest Forecast
Price Target
858.6 EUR
86% Upside
Madrigal Pharmaceuticals Inc Competitors:
Price Targets
AREC
American Resources Corp
173% Upside
TELA
TELA Bio Inc
125% Upside
CENT
Central Garden & Pet Co
29% Upside
CASY
Caseys General Stores Inc
-13% Downside
NCSM
NCS Multistage Holdings Inc
74% Upside
PRQR
ProQR Therapeutics NV
481% Upside

Revenue
Forecast

41% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
41% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 8 years is 26%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is YDO1's stock price target?
Price Target
570.64 EUR

According to Wall Street analysts, the average 1-year price target for YDO1 is 570.64 EUR with a low forecast of 453.21 EUR and a high forecast of 858.6 EUR.

What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
26%

Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 8 years is 26%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett